APA (7th ed.) Citation

Leiter-Stöppke, U., Loquai, C., Reinhardt, L., Rafei-Shamsabadi, D., Gutzmer, R., Kaehler, K., . . . Ugurel, S. (2020). Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: A retrospective multicenter DeCOG study of 84 patients. Journal for ImmunoTherapy of Cancer, 8(2), . https://doi.org/10.1136/jitc-2020-000897

Chicago Style (17th ed.) Citation

Leiter-Stöppke, Ulrike, et al. "Immune Checkpoint Inhibition Therapy for Advanced Skin Cancer in Patients with Concomitant Hematological Malignancy: A Retrospective Multicenter DeCOG Study of 84 Patients." Journal for ImmunoTherapy of Cancer 8, no. 2 (2020). https://doi.org/10.1136/jitc-2020-000897.

MLA (9th ed.) Citation

Leiter-Stöppke, Ulrike, et al. "Immune Checkpoint Inhibition Therapy for Advanced Skin Cancer in Patients with Concomitant Hematological Malignancy: A Retrospective Multicenter DeCOG Study of 84 Patients." Journal for ImmunoTherapy of Cancer, vol. 8, no. 2, 2020, https://doi.org/10.1136/jitc-2020-000897.